Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The PD-1/PD-L1 axis is a key immune checkpoint regulating T cell activity.
• Tumor cells exploit this axis to escape immune surveillance by upregulating PD-L1.
• While PD-1/PD-L1 blockade therapies show promise, non-response in some patients necessitates further investigation.

Purpose of the Study:

• To systematically review the regulatory mechanisms controlling PD-1 and PD-L1 expression in the tumor microenvironment.
• To elucidate factors influencing PD-L1 surface availability and inhibitor sensitivity.
• To discuss current clinical trials and future research directions for PD-1/PD-L1 targeted therapies.

Main Methods:

• Systematic literature review of PD-1/PD-L1 regulation.
• Analysis of genetic, epigenetic, transcriptional, and posttranscriptional control mechanisms.
• Examination of posttranslational modifications and membrane trafficking of PD-L1.

Main Results:

• PD-1 and PD-L1 expression is tightly regulated at multiple molecular levels.
• Posttranslational modifications and cellular trafficking significantly impact PD-L1 function and therapeutic response.
• The review consolidates current understanding of PD-1/PD-L1 axis regulation in cancer.

Conclusions:

• Understanding the multifaceted regulation of PD-1/PD-L1 is essential for overcoming immunotherapy resistance.
• Further research into these regulatory pathways can guide the development of more effective cancer treatments.
• Targeting PD-1/PD-L1 interactions remains a critical strategy in immuno-oncology.